scholarly journals Heat Stress Cognate 70 Host Protein as a Potential Drug Target against Drug Resistance in Hepatitis B Virus

2010 ◽  
Vol 54 (5) ◽  
pp. 2070-2077 ◽  
Author(s):  
Y. P. Wang ◽  
F. Liu ◽  
H. W. He ◽  
Y. X. Han ◽  
Z. G. Peng ◽  
...  
2011 ◽  
Vol 54 (3) ◽  
pp. 869-876 ◽  
Author(s):  
Li-Mei Gao ◽  
Yan-Xing Han ◽  
Yu-Ping Wang ◽  
Yu-Huan Li ◽  
Yong-Qiang Shan ◽  
...  

1998 ◽  
Vol 18 (12) ◽  
pp. 7546-7555 ◽  
Author(s):  
Dorjbal Dorjsuren ◽  
Yong Lin ◽  
Wenxiang Wei ◽  
Tatsuya Yamashita ◽  
Takahiro Nomura ◽  
...  

ABSTRACT To modulate transcription, regulatory factors communicate with basal transcription factors and/or RNA polymerases in a variety of ways. Previously, it has been reported that RNA polymerase II subunit 5 (RPB5) is one of the targets of hepatitis B virus X protein (HBx) and that both HBx and RPB5 specifically interact with general transcription factor IIB (TFIIB), implying that RPB5 is one of the communicating subunits of RNA polymerase II involved in transcriptional regulation. In this context, we screened for a host protein(s) that interacts with RPB5. By far-Western blot screening, we cloned a novel gene encoding a 508-amino-acid-residue RPB5-binding protein from a HepG2 cDNA library and designated it RPB5-mediating protein (RMP). Expression of RMP mRNA was detected ubiquitously in various tissues. Bacterially expressed recombinant RMP strongly bound RPB5 but neither HBx nor TATA-binding protein in vitro. Endogenous RMP was immunologically detected interacting with assembled RPB5 in RNA polymerase in mammalian cells. The central part of RMP is responsible for RPB5 binding, and the RMP-binding region covers both the TFIIB- and HBx-binding sites of RPB5. Overexpression of RMP, but not mutant RMP lacking the RPB5-binding region, inhibited HBx transactivation of reporters with different HBx-responsive cis elements in transiently transfected cells. The repression by RMP was counteracted by HBx in a dose-dependent manner. Furthermore, RMP has an inhibitory effect on transcriptional activation by VP16 in the absence of HBx. These results suggest that RMP negatively modulates RNA polymerase II function by binding to RPB5 and that HBx counteracts the negative role of RMP on transcription indirectly by interacting with RPB5.


2017 ◽  
pp. 1227-1242 ◽  
Author(s):  
Apostolos Beloukas ◽  
Anna Maria Geretti

2004 ◽  
pp. 379-386
Author(s):  
Eric J. Bourne ◽  
Josée Gauthier ◽  
Vincent A. Lopez ◽  
Lynn D. Condreay

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Elin Teppa ◽  
Francesca Nadalin ◽  
Christophe Combet ◽  
Diego Javier Zea ◽  
Laurent David ◽  
...  

Abstract The study of mutational landscapes of viral proteins is fundamental for the understanding of the mechanisms of cross-resistance to drugs and the design of effective therapeutic strategies based on several drugs. Antiviral therapy with nucleos(t)ide analogues targeting the hepatitis B virus (HBV) polymerase protein (Pol) can inhibit disease progression by suppression of HBV replication and makes it an important case study. In HBV, treatment may fail due to the emergence of drug-resistant mutants. Primary and compensatory mutations have been associated with lamivudine resistance, whereas more complex mutational patterns are responsible for resistance to other HBV antiviral drugs. So far, all known drug-resistance mutations are located in one of the four Pol domains, called reverse transcriptase. We demonstrate that sequence covariation identifies drug-resistance mutations in viral sequences. A new algorithmic strategy, BIS2TreeAnalyzer, is designed to apply the coevolution analysis method BIS2, successfully used in the past on small sets of conserved sequences, to large sets of evolutionary related sequences. When applied to HBV, BIS2TreeAnalyzer highlights diversified viral solutions by discovering thirty-seven positions coevolving with residues known to be associated with drug resistance and located on the four Pol domains. These results suggest a sequential mechanism of emergence for some mutational patterns. They reveal complex combinations of positions involved in HBV drug resistance and contribute with new information to the landscape of HBV evolutionary solutions. The computational approach is general and can be applied to other viral sequences when compensatory mutations are presumed.


2014 ◽  
Vol 88 (12) ◽  
pp. 6805-6818 ◽  
Author(s):  
S. H. Ahn ◽  
Y. K. Park ◽  
E.-S. Park ◽  
J. H. Kim ◽  
D. H. Kim ◽  
...  

2003 ◽  
Vol 38 ◽  
pp. 7
Author(s):  
D. Durantel ◽  
S. Durantel ◽  
C. Pichoud ◽  
B. Werle ◽  
M.-N. Brunelle ◽  
...  

2011 ◽  
Vol 49 (3) ◽  
pp. 1017-1024 ◽  
Author(s):  
S. Fujisaki ◽  
Y. Yokomaku ◽  
T. Shiino ◽  
T. Koibuchi ◽  
J. Hattori ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document